Womed
Montpellier
About Womed
Womed Leaf stems from research conducted at Pr Garric's biopolymer lab at the University of Montpellier, France, and which aimed at finding an elegant solution to an unmet medical need in gynecologic surgery: intrauterine adhesions. The research project started in 2013 and was conducted as the thesis work of several PhD students. At the conclusion of the thesis, the lab looked for an industrial partner to commercialize the invention. Womed SAS was incorporated in 2018 for that purpose.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $6.6M
- Funding stage: M&A
- Last round: Grant (Feb 2024)
- Website: womedtech.com
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/womed-42804 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.